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Background: HIV-1 entry into target lymphocytes requires the activity of actin adaptors that stabilize and reorganize
cortical F-actin, like moesin and filamin-A. These alterations are necessary for the redistribution of CD4-CXCR4/CCR5 to
one pole of the cell, a process that increases the probability of HIV-1 Envelope (Env)-CD4/co-receptor interactions and
that generates the tension at the plasma membrane necessary to potentiate fusion pore formation, thereby favouring
early HIV-1 infection. However, it remains unclear whether the dynamic processing of F-actin and the amount of
cortical actin available during the initial virus-cell contact are required to such events.
Results: Here we show that gelsolin restructures cortical F-actin during HIV-1 Env-gp120-mediated signalling, without
affecting cell-surface expression of receptors or viral co-receptor signalling. Remarkably, efficient HIV-1
Env-mediated membrane fusion and infection of permissive lymphocytes were impaired when gelsolin was either
overexpressed or silenced, which led to a loss or gain of cortical actin, respectively. Indeed, HIV-1 Env-gp120-induced
F-actin reorganization and viral receptor capping were impaired under these experimental conditions. Moreover,
gelsolin knockdown promoted HIV-1 Env-gp120-mediated aberrant pseudopodia formation. These perturbed-actin
events are responsible for the inhibition of early HIV-1 infection.
Conclusions: For the first time we provide evidence that through its severing of cortical actin, and by controlling the
amount of actin available for reorganization during HIV-1 Env-mediated viral fusion, entry and infection, gelsolin can
constitute a barrier that restricts HIV-1 infection of CD4+ lymphocytes in a pre-fusion step. These findings provide
important insights into the complex molecular and actin-associated dynamics events that underlie early viral infection.
Thus, we propose that gelsolin is a new factor that can limit HIV-1 infection acting at a pre-fusion step, and
accordingly, cell-signals that regulate gelsolin expression and/or its actin-severing activity may be crucial to combat
HIV-1 infection.
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The host cell cytoskeleton plays a key role in the life cycle
of viral pathogens, the propagation of which depends on
several mandatory intracellular stages. Accordingly, the
human immunodeficiency virus type 1 (HIV-1) has
evolved strategies to exploit and modulate the actin cyto-
skeleton for its own purposes [1-3]. The entry of HIV-1* Correspondence: avalenzu@ull.edu.es
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distribution, and reproduction in any mediuminto a target cell requires the interaction of multiple re-
ceptor and co-receptor molecules with each viral envelope
(Env) trimer in order to promote the formation of fusion
pores [4,5]. The HIV-1 Env gp120 protein regulates the
initial attachment of viral particles to target cells through
its association with CD4 and either CXCR4 or CCR5,
which results in the exposure of the fusion-promoting
peptide of the Env gp41 region. Moreover, HIV-1 induces
the activation of moesin, an actin-adaptor protein, to
promote the redistribution of F-actin and CD4/CXCR4
clustering on the cell surface at viral entry points [6].
These events are crucial to ensure efficient HIV-1/cell-
membrane fusion, viral entry and infection in TCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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spatial association between moesin phosphorylation
and F-actin-mediated viral receptor capping that pro-
motes HIV-1 infection.
HIV-1 Env-gp120-dependent actin remodelling also
involves the actin-crosslinker filamin-A, Rho-A and Rac
guanosine-triphosphatases (GTPases), and the actin-
depolymerization factors cofilin [7-9] and syntenin-1
[10]. Filamin-A binds to the cytoplasmic tails of CD4
and viral co-receptors, and the ensuing HIV-1 Env-
gp120-dependent signalling activates Rho-A [7] and
Rac1 [9]. Both Rho-A and the Rac GTPase activate the
LIM domain kinase, which phosphorylates and inacti-
vates cofilin, in turn triggering early actin polymerization
[9]. Together, these processes increase the probability of
HIV-1 Env-CD4/co-receptor interactions, potentiating
fusion pore formation and hence, HIV-1 viral fusion and
infection (reviewed in [1-3]). Cofilin and syntenin-1
appear to depolymerise F-actin in a post-fusion step,
allowing the entry of the viral capsid into target cells
[8,10]. However, the HIV-1 Env signalling that lies up-
stream of the Rho-A/Rac-LIMK-cofilin and syntenin-1
pathways remain poorly understood [10-13], and the
identity of the kinase that phosphorylates moesin in the
ERM complex is unknown [6]. Likewise, the processes
underlying the recruitment and activation of the differ-
ent actin remodelling factors due to HIV-1 Env signal-
ling through CD4 and its co-receptors remain to be
elucidated.
Gelsolin belongs to a superfamily of actin binding pro-
teins expressed in all eukaryotes that includes villin,
adseverin (also known as scinderin), CapG, flil and
severin (also known as fragmin: reviewed in [14]). All
members of this family contain at least one 120 amino
acid structural repeat and many have three or six
gelsolin repeats [15]. Gelsolin is an 80-kDa protein
consisting of two tandem homologous fragments (seg-
ments 1–3 and 4–6) that each contains three repeats
[16]. This protein trims large actin filaments, promoting
actin cytoskeleton reorganization, and it alters plasma
membrane morphology to generate motile filopodia and
lamellipodia [17-19].
Given the actin-severing activity of gelsolin and the
fundamental role of HIV-1 Env-gp120-orchestrated
cortical actin reorganization in virus-mediated receptor
aggregation, as well as in efficient HIV-1 fusion and
entry, we investigated the functional role of intracellular
gelsolin in early HIV-1 infection in permissive lympho-
cytes. We found that overexpression of functional intra-
cellular gelsolin or specific silencing of endogenous
gelsolin expression restricts HIV-1 entry and infection
by altering the amounts of cortical F-actin, and by
perturbing F-actin dynamics and the associated changes
in pseudopodium morphology. We observed that theseevents negatively affect HIV-1 Env-mediated receptor
clustering, membrane fusion and efficient viral entry and
infection. Based on these findings, we propose that
gelsolin can restrict early HIV-1 infection acting at a pre-
fusion step, and altering the stability and dynamics of the
cortical actin cytoskeleton in permissive lymphocytes.
Results
The actin-severing enzyme gelsolin is expressed in the
cytoplasm and cortex of cells, where it regulates F-actin
levels
To explore the roles of gelsolin and its F-actin sever-
ing activity in early HIV-1 entry and infection, we
used a C-terminal enhanced green fluorescent protein
(EGFP)-tagged wild type gelsolin (gelsolin-EGFP) derived
from the permissive CEM.NKR-CCR5 T cell line. Transient
expression of the gelsolin-EGFP construct (Figure 1A) in
these permissive lymphocytes was confirmed in Western
blots and by flow cytometry. Fluorescence confocal
microscopy revealed that cortical gelsolin-EGFP co-
localizes with cortical F-actin in the cytoplasm of CEM.
NKR-CCR5 cells (Figure 1B, C), a similar distribution to
that observed for endogenous gelsolin (Figure 1D). Trans-
fection of a construct encoding the EGFP protein alone (as
a control) revealed a clear cytoplasmic distribution, with no
expression associated with the plasma membrane or actin
filaments (Figure 1B, pEGFP-N1 series of images). In T cells
transfected with gelsolin-EGFP, F-actin expression was di-
minished, as monitored by the intensity of the labelling of
cortical F-actin, which was weaker than in cells expressing
EGFP alone (Figure 1C, line scan analysis and quantifica-
tion histograms) and in non-transfected cells (Figure 1D).
These data were confirmed by quantifying total levels of
F-actin expression by flow cytometry (Figure 1B, right histo-
gram), which revealed that gelsolin-EGFP overexpression
promoted actin filament severing and decreased the
levels of cortical F-actin in CEM.NKR-CCR5 permis-
sive lymphocytes. Our data demonstrate that the func-
tional gelsolin construct and the endogenous gelsolin
protein both co-localize with F-actin, in agreement
with previous reports describing the binding of
gelsolin to actin filaments, even during actin filament
processing [20,21].
Gelsolin restricts HIV-1 entry and infection in permissive
lymphocytes, independently of viral tropism
Since HIV-1 Env-gp120-induced reorganization of cortical
actin has been proposed to be fundamental to promote ef-
ficient HIV-1 viral entry and infection [6-9], we therefore
examined the effect of gelsolin overexpression on HIV-1
entry and infection. Overexpression of gelsolin-EGFP did
not affect the cellular distribution or the cell-surface
expression of CD4, CXCR4 or CCR5, the receptors re-
quired for HIV-1 infection (Figures 2A, B, respectively).
Figure 1 Expression of functionally overexpressed or endogenous gelsolin and its effects on cortical F-actin. (A) Left, Western blot of
gelsolin-EGFP expression in CEM.NKR-CCR5 cells. Gelsolin-EGFP fusion protein was stable and did not undergo any processing of its C-terminal
EGFP tag. α-tubulin and pEGFP-N1 are controls for total protein and free EGFP, respectively. Right, Quantification of gelsolin-EGFP (45.2%) and free
EGFP (56.9%) expressing cells by flow cytometry. One representative experiment of three is shown. (B) Left, a series of confocal images, xy midsections,
showing the distribution of overexpressed gelsolin-EGFP. F-actin, free EGFP and merged images for F-actin/gelsolin-EGFP co-localization at cell-surface
are shown. One representative experiment of three different experiments is shown. Right, flow cytometry analysis of F-actin in EGFP- (control, taken as
100% F-actin expression) or gelsolin-EGFP- expressing cells. Data are mean ± s.e.m of three independent experiments: *p < 0.05, Student’s t-test. (C) Left,
line scans show the fluorescence intensity profiles of cortical F-actin and the overexpressed free EGFP or gelsolin-EGFP proteins. Images correspond to the
results presented in the merged images in panel B, analysed along the horizontal line drawn in panel C. Right, quantification of the fluorescence intensity
profiles of cortical F-actin in a series of cells (12 cells per series) analysed by line scanning confocal microscopy (8 cortical points analyzed per cell). Data are
mean ± s.e.m. of three independent experiments: **p < 0.01, Student’s t-test. (D) Left, a series of confocal images showing the distribution of endogenous
gelsolin. F-actin and merged images for F-actin/gelsolin co-localization at cell-surface are shown. One representative experiment of three is shown. Right,
Western blot analysis of endogenous gelsolin and F-actin expression. α-tubulin is a control of total protein expression. One representative experiment of
three is shown. In B, C and D, scale bar = 5 μm.
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Figure 2 Functional gelsolin overexpression impairs HIV-1 entry and infection in permissive lymphocytes, regardless of viral tropism.
(A) CD4 and CXCR4 (top images) or CCR5 (bottom images) distribution in uninfected CEM.NKR-CCR5 cells transfected with free EGFP (pEGFP-N1)
or gelsolin-EGFP. Merged confocal microscopy images show the co-localization of CD4-CXCR4/gelsolin-EGFP or CD4-CCR5/gelsolin-EGFP at the
plasma membrane. Scale bar = 5 μm; one representative experiment of three is shown, always analyzing 200 cells. (B) Flow cytometry analysis of
the effect of gelsolin-EGFP or EGFP overexpression (control, 100% viral receptor expression in pEGFP-N1-transfected cells) on CD4, CXCR4 and
CCR5 cell-surface expression. (C) Effect of gelsolin-EGFP overexpression on SDF-1α-induced CXCR4 endocytosis. Control (EGFP-transfected cells)
and gelsolin-EGFP expressing cells were exposed to SDF-1α (50 nM and 200 nM), as described in Methods. CXCR4 expression was subsequently
analyzed by flow cytometry in control/EGFP + and gelsolin-EGFP + cells using PE-conjugated specific mAbs against cell-surface CXCR4. The data
are expressed as a percentage of CXCR4 expression in the absence of SDF-1α (control). (D) Luciferase assay of viral entry and infection by X4- and
R5-tropic HIV-1 viral particles in gelsolin-EGFP transfected cells (EGFP-expressing cells were used as controls, and represent 100% viral entry and
infection). All the data were corrected using the non-productive infection values (baseline) obtained in the presence of a neutralizing anti-CD4
mAb (5 μg/mL) under the same experimental conditions. A luciferase-based assay, with equal inputs of pseudotyped VSV-G virions was used to
control the specificity of gelsolin-mediated effects on HIV-1 viral entry and infection. These data were corrected with non-productive baseline
values obtained using non-infective virus-like particles lacking VSV-G-Env under the same experimental conditions. In B-D data are mean ± s.e.m.
of three independent experiments carried out in triplicate: *** p < 0.001, Student’s t-test.
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Figure 3 (See legend on next page.)
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Figure 3 Effect of gelsolin overexpression on HIV-1 Env-gp120-induced cortical F-actin redistribution in permissive lymphocytes.
(A) Confocal analysis of HIV-1 Env-gp120-induced F-actin redistribution in CEM.NKR-CCR5 cells expressing free EGFP (controls) or gelsolin-EGFP. In
control cells, rs-gp120IIIB (5 μg/mL) triggered F-actin capping (see white asterisk). F-actin expression was clearly visible in control conditions (see
white arrowhead in pEGFP-N1 images) but was reduced in cells expressing gelsolin-EGFP. Merged images show the cortical co-localization of F-
actin and gelsolin-EGFP or free EGFP. Right histograms, rs-gp120IIIB-triggered cortical F-actin capping is represented as the percentage of 200 cells
counted for each experimental condition. Scale bar = 5 μm. A series of xy midsections from one representative experiment out of three is shown.
(B) Similar data was obtained by confocal analysis of HIV-1 Env-gp120-induced F-actin redistribution in CEM.NKR-CCR5 cells expressing free EGFP
(controls) or co-expressing both free gelsolin and EGFP. In control cells, rs-gp120IIIB (5 μg/mL) triggered F-actin capping (see white asterisk). F-actin
expression was clearly visible in control conditions (see white arrowhead in EGFP-pSUPER images) but was reduced in cells expressing EGFP-pSUPER
-gelsolin. Merged images show the cortical co-localization of F-actin and gelsolin or free EGFP. Cortical F-actin capping (only observed in EGFP-pSUPER
condition) or distribution is represented as the percentage of 200 cells counted for each experimental condition. Scale bar = 5 μm. A series of xy
midsections from one representative experiment out of three is shown.
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were observed in cells overexpressing gelsolin, indicating
that these viral co-receptors were fully functional
(Figure 2C).
We next studied early HIV-1 infection using single-
cycle viruses bearing the Luc-reporter gene in permissive
lymphocytes overexpressing functional gelsolin. These
non-replicative viruses enable HIV-1 entry and infection
to be monitored and quantified [6,22-24], excluding any
potential influence of the late stages of the infection
cycle. When X4- or R5-tropic HIV-1 viral particles were
incubated with CEM.NKR-CCR5 permissive cells, HIV-1
entry and infection was significantly impaired in
gelsolin-EGFP-expressing cells as compared with control
cells (Figure 2D), with a similar impairment of both the
X4- or R5-tropic HIV-1 viral strains (Figure 2D; 54%
and 58% of X4-tropic and R5-tropic infection, respect-
ively). Thus, the actin-severing gelsolin protein modu-
lated HIV-1 entry and infection regardless of viral
tropism, indicating that the inhibitory effect of gelsolin
on early HIV-1 infection is not related to defective
signalling or decreased cell-surface expression of viral
co-receptors.
We also assayed the effect of gelsolin overexpression
on pseudotyped virions carrying the vesicular stomatitis
virus (VSV)-G Env protein [6,22-24] that enter target
cells using the clathrin-endocytic lower-pH pathway
selected by VSV-G Env [24,25]. Entry and infection of
these pseudotyped viral particles, using equal viral in-
puts for these virions and that for X4- and R5-tropic
HIV-1 strains, were not significantly affected by gelsolin
overexpression (Figure 2D).
Together, these observations suggest that overexpression
of functional gelsolin restricts HIV-1 entry and infection of
permissive lymphocytes regardless of viral tropism. It is
conceivable that overexpression of gelsolin perturbs the
HIV-1 Env-gp120-mediated cortical actin reorganization
and dynamics, a process that may also be affected by a
reduction in the pool of cortical actin. To address this
issue, we studied the role of gelsolin in HIV-1 Env-
mediated actin reorganization.Gelsolin overexpression impairs HIV-1 Env-gp120-induced
cortical F-actin reorganization and capping
The role of gelsolin in HIV-1 Env-gp120-mediated F-actin
reorganization was studied by transiently nucleofecting
permissive lymphocytes with gelsolin-EGFP and then in-
cubating them with functional, recombinant soluble HIV-1
Env-gp120 viral protein (rs-gp120IIIB). This viral protein
promotes a reorganization of cortical actin to one pole of
the cell in a CD4-dependent manner [6,22], as evident
when cells overexpressing EGFP alone were exposed to the
HIV-1 Env-gp120 protein (Figure 3A, pEGFP-N1 images;
quantified in histograms, 33% of cells). However, the cor-
tical actin clustering induced by rs-gp120IIIB was impaired
in permissive lymphocytes overexpressing gelsolin-EGFP
(Figure 3A, gelsolin-EGFP series of images, quantified in
histograms, 22% of cells). We next analyzed the HIV-1 Env-
gp120-mediated F-actin reorganization in permissive lym-
phocytes transiently expressing both free EGFP and gesolin
(encoded in the same EGFP-pSUPER-gelsolin plasmid)
or free EGFP alone (encoded in a control EGFP-
pSUPER plasmid), in order to explore whether or not the
EGFP tag alters or conditions the observed effects attrib-
uted to gelsolin. HIV-1 Env-gp120-induced F-actin cap-
ping was similarly observed in control cells, expressing
only free EGFP (Figure 3B, 30% of cells). As occurred in
cells over-expressing gelsolin-EGFP (Figure 3A, 78% of
non-reactive cells), the cortical actin clustering induced by
rs-gp120IIIB was impaired in permissive lymphocytes co-
overexpressing free gelsolin and EGFP (Figure 3B, EGFP-
pSUPER-gelsolin series of images; 75% of non reactive
cells). Some endogenous gelsolin was detected within the
F-actin capping region in this case (Figure 3B, see Gelsolin
and F-actin in the EGFP-pSUPER (+) rs-gp120 series of
images), but was not tightly restricted to the region of the
actin cap, and endogenous gelsolin was also observed in
the cytoplasm and at the plasma membrane of these acti-
vated cells. Therefore, over-expression of free gelsolin
inhibits rs-gp120IIIB-induced F-actin reorganization and
capping to a pole of the cell (Figure 3B). The EGFP moiety
on gelsolin-EGFP does not appear to be responsible of or
to significantly alter the effect exerted by over-expressed
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reorganization and capping. Taken together these data
suggest that efficient early HIV-1 infection requires the
appropriate amount of cortical actin to be reorganized in
a specific manner during the initial virus-cell contacts.Figure 4 Gelsolin functional overexpression impairs HIV-1 Env-gp120
lymphocytes. (A) Left, HIV-1 Env-gp120-induced redistribution of CD4-CXC
EGFP, 1 hour of after exposure to rs-gp120IIIB (5 μg/mL) at 37°C. A series of
co-localization at cell-surface are shown. Scale bar = 5 μm. One representat
CD4-CXCR4 capping is reflected as the percentage of 200 cells counted for
of three independent experiments. (B) Analysis and quantification of HIV-1
expressing gelsolin-EGFP or EGFP. A series of xy midsections and merged i
surface. Scale bar = 5 μm. One representative experiment of three is shown
percentage of 200 cells counted for each experimental condition, where thBoth these processes appear to be influenced by actin-
severing gelsolin, suggesting that gelsolin activity can
restrict HIV-1 entry and infection. Therefore, both
overexpression of functional gelsolin or specific knock-
down of endogenous gelsolin negatively affects HIV-1-mediated CD4-CXCR4 and CD4-CCR5 redistribution in permissive
R4 to the cell pole in CEM.NKR-CCR5 cells expressing gelsolin-EGFP or
xy midsections and merged images for CD4-CXCR4/gelsolin-EGFP
ive experiment of three is shown. Right, HIV-1 Env-gp120-induced
each experimental condition, where the data represent the results
Env-gp120-induced CD4-CCR5 redistribution in permissive cells
mages show the co-localization of CD4-CCR5/gelsolin-EGFP at the cell
. Right, HIV-1 Env-gp120-induced CD4-CCR5 capping is shown as the
e data represent the results of three independent experiments.
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pre-fusion step.Overexpression of functional gelsolin inhibits HIV-1
Env-gp120-mediated viral receptor redistribution and
clustering
Confocal microscopy revealed significant CD4-CXCR4 clus-
tering at one pole of the cell upon rs-gp120IIIB-mediated
stimulation of control lymphocytes (Figure 4A, pEGFP-N1
images quantified in the histogram on the right, 30% of
cells), as described previously [6]. When compared with
EGFP-transfected cells, this gp120-induced CD4-CXCR4
capping was impaired in cells overexpressing functional
gelsolin-EGFP (Figure 4A, gelsolin-EGFP images quan-
tified in the histogram on the right, 20% of cells) and
similarly, rs-gp120 protein-induced CD4-CCR5 capping
was blocked in permissive lymphocytes transiently
transfected with gelsolin-EGFP (Figure 4B, gelsolin-EGFP
images quantified in histogram, 19% of cells). These find-
ings suggest that an increase in the actin-severing capacity
induced by functional gelsolin overexpression provokes
defective HIV-1 Env-gp120-mediated CD4-CXCR4 and -
CCR5 capping at the cell surface, which may account forFigure 5 Gelsolin functional overexpression impairs HIV-1 Env-gp120
Effect of gelsolin-EGFP (A) or free gelsolin (B; co-expressed with free EGFP using
HIV-1 Env-mediated membrane fusion measured by β-Galactosidase producti
membrane fusion). Treated HeLa P5 cells were fused with HeLa cells expressin
an anti-CD4 mAb. The data represent the mean ± s.e.m. of four independent
blot quantification of gelsolin-EGFP (A), free EGFP (A and B) and gelsolin (B; d
with total α-tubulin levels prior to cell-to-cell fusion, showing representative d
receptors was analyzed under each experimental condition (A and B). Data re
in triplicate.the blockade of HIV-1 infection by X4- and R5-tropic
viruses, as described previously [6,7,9].
Over-expression of gelsolin inhibits HIV-1 Env-mediated
cell-to-cell fusion, regardless of viral tropism
We assessed the effect of gelsolin activity on the gp120/gp41
fusion capacity in permissive HeLa P5 cells (Figure 5), in
order to ascertain whether actin-severing gelsolin inhibits
early HIV-1 infection during pore fusion formation or at a
post-fusion step. In agreement with the previous experiments
on permissive lymphocytes, the expression of CD4, CXCR4,
and CCR5 was not modified by the overexpression of
gelsolin-EGFP or free gelsolin, in these HeLa P5 cells
(Figure 5A or B, respectively; see cell-surface expression and
Western blots). Under these conditions, gelsolin-EGFP
-transfected HeLa P5-permissive cells were much less
susceptible to fuse with HeLa cells stably expressing X4- or
R5-tropic Env (Figure 5A, 64% and 56% of inhibition, re-
spectively), compared to EGFP expressing cells (Figure 5A).
Moreover, fusion with X4- and R5-tropic Env + cells was
impaired in gelsolin-transfected HeLa P5 cells (Figure 5B,
71% and 68% of inhibition, respectively). These results indi-
cate that the efficiency of early HIV-1 infection is negatively
regulated by overexpression of actin-severing gelsolin, which-mediated cell-to-cell fusion, regardless of viral Env tropism.
an EGFP-pSUPER-gelsolin plasmid) overexpression in HeLa P5 cells on
on, and referred to the EGFP or EGFP-pSUPER control condition (100% of
g X4-tropic (243) or R5-tropic (ADA) Env, in the presence or absence of
experiments carried out in triplicate: ** p < 0.01, Student’s t-test. Western
etection of endogenous and overexpressedfree gelsolin) expression together
ata for each experimental condition. Cell-surface expression of viral
present the mean ± s.e.m. of four independent experiments carried out
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fusion step, constituting a process that appears to be directly
related to the F-actin cortical content and dynamics.
Specific RNA interference of endogenous gelsolin inhibits
early HIV-1 infection and HIV-1 Env-mediated membrane
fusion
To further demonstrate the involvement of gelsolin in
early HIV-1 infection, we studied the effects of silencing
endogenous gelsolin expression in permissive lympho-
cytes with specific small interfering RNA (siRNA) oligo-
nucleotides (oligos) against gelsolin (siRNA-GSN). Two
different siRNAs were administered independently or in
combination (siRNA1-GSN or siRNA2-GSN and siRNA
(1 + 2)-GSN), which effectively silenced endogenous
gelsolin expression (Figure 6A) without affecting the
cell-surface expression of HIV-1 receptors (Figure 6B).
Silencing endogenous gelsolin expression in permissive
lymphocytes markedly enhanced the accumulation of
cortical F-actin compared with non-interfered cells
(asterisk in Figure 6C or D compared with neighbouring
cell; see line scan analysis) or with control cells
transfected with scrambled siRNA (control in Figure 6C,
and Figure 6D, histograms line scan). These data were
confirmed by quantifying total levels of F-actin expres-
sion by flow cytometry (Figure 6E), which revealed that
gelsolin knockdown increases the levels of F-actin in
CEM.NKR-CCR5 permissive lymphocytes. Moreover,
silencing endogenous gelsolin expression negatively
affected HIV-1 entry and infection in function of the
degree to which endogenous gelsolin was silenced
(Figure 7A). The inhibition of HIV-1 entry and infection
again appeared to be independent of viral tropism as no
differences were observed between gelsolin-silenced per-
missive lymphocytes infected with X4- or R5-tropic
HIV-1 viral strains (Figure 7A).
The entry and infection of VSV-G pseudotyped viral
particles, using equal viral inputs for these virions that
for X4- and R5-tropic HIV-1 strains, were not affected
by the specific silencing of endogenous gelsolin using
siRNA1-GSN or siRNA2-GSN oligos (Figure 7A). There-
fore, it appears that gelsolin silencing specifically affects
HIV-1 Env-mediated viral entry and infection. However,
we cannot fully rule out the involvement of gelsolin in
endocytic VSV-G-driven viral entry, where it may affect
specific actin structures associated with the clathrin-
endocytic system. As such, further studies will be
required to determine the role of the gelsolin/actin sys-
tem during early VSV-G infection. Moreover, gelsolin
knockdown (Figure 7B, Western blot) inhibits HIV-1
Env-mediated cell-to-cell fusion, regardless of HIV-1
Env tropism and without affecting HIV-1 cell-surface re-
ceptors on HeLa P5 permissive cells (Figure 7B). Of
note, overexpression of EGFP or gelsolin-EGFP ornucleofection of scrambled or siRNA(1 + 2)-GSN oligos
did not induce cellular toxicity in CEM-CCR5 or HeLa
P5 permissive cells (Additional file 1).
Together, these findings suggest that endogenous
gelsolin severs the cortical actin cytoskeleton to main-
tain the appropriate amount of F-actin that ensures cor-
rect dynamic actin reorganization during early HIV-1
entry and infection, and acting on the HIV-1 Env-induced
virus/cell-membrane fusion process. Thus, alteration of
endogenous gelsolin expression or activity, and subse-
quent cortical actin amount restrict early HIV-1 infection
at a pre-fusion step.
Knockdown of endogenous gelsolin impairs HIV-1
Env-gp120-mediated F-actin reorganization and viral
receptor clustering
To study the effect of gelsolin knockdown on the redistri-
bution of cortical actin and the changes in cell morphology
induced by HIV-1 Env-gp120, permissive lymphocytes
transfected with siRNA(1 + 2)-GSN or with scrambled
oligos were analysed by confocal microscopy (Figure 8).
Cells exhibited a normal morphology and cortical F-actin
distribution in the absence of stimulation by HIV-1
Env-gp120 (Figure 8A, panel a1) and in these condi-
tions, transfection with siRNA(1 + 2)-GSN (fluorescent
oligos) reduced the expression of endogenous gelsolin
in conjunction with an increase in the amount of cor-
tical F-actin (Figure 8A, panel a1). In permissive cells,
cortical actin was redistributed to one of the poles of
the cell when incubated with the rs-gp120IIIB viral pro-
tein, forming a discrete cap of F-actin that in some cases
morphologically resembled a small pseudopodium
(Figure 8A, panel a2, 11% of cells). Indeed, the majority of
reactive control cells exhibited a prominent pseudopo-
dium that developed in the region of the F-actin cap
(Figure 8A, panel a3, 25% of cells). These large pseudopo-
dia containing reorganized cortical actin and they are indi-
cative of efficient cellular activation by the viral Env-gp120
protein, as described previously [6]. While some endogen-
ous gelsolin was detected within the F-actin capping re-
gion in all these cases (Figure 8A, panels a2 and a3, 36%
of total capped cells), it was not tightly restricted to the re-
gion of the actin cap, and endogenous gelsolin was also
observed in the cytoplasm and at the plasma membrane
of these activated cells (Figure 8A, panels a2 and a3).
This event was also observed in HIV-1 Env-gp120-trig-
gered permissive lymphocytes over-expressing free EGFP
(Figure 3B, EGFP-pSUPER (+) rs-gp120 series of images).
Remarkably, in cells transfected with siRNA(1 + 2)-GSN,
redistribution of F-actin to one of the poles was not
observed, and no pseudopodia were formed (similar as
observed in panel a1, siRNA(1 + 2)-GSN cells). When
gelsolin-silenced cells were stimulated with rs-gp120IIIB
pseudopodia with aberrant morphologies were formed in
Figure 6 Specific silencing of endogenous gelsolin and its effects on cortical F-actin, in permissive lymphocytes. (A) Western blot of
endogenous gelsolin knockdown in permissive lymphocytes transfected with two siRNA-GSN oligos, either individually (siRNA1-GSN or siRNA2-
GSN) or combined (siRNA(1 + 2)-GSN), normalized to the expression of total α-tubulin. Cells transfected with scrambled siRNA were used as
control. One representative experiment of three is shown. (B) Flow cytometry analysis of CD4, CXCR4 and CCR5 cell-surface expression in
lymphocytes transfected with scrambled siRNA, siRNA1-GSN or siRNA2-GSN. (C) Confocal analysis of F-actin and endogenous gelsolin expression
in siRNA(1 + 2)-GSN-treated lymphocytes, using a mixture of fluorescent Alexa-546 oligos. Fluorescent scrambled Alexa 546 was used as a control.
White asterisks indicate cells in which endogenous gelsolin expression was efficiently silenced, expressing more cortical F-actin than in their
neighbouring cells in which the uptake of siRNA(1 + 2)-GSN oligos was insufficient to silence gelsolin expression. xy midsections and merged
images from a representative experiment are shown. Scale bar = 5 μm. (D) Line scans show fluorescence intensity profiles of cortical F-actin in
silenced, siRNA(1 + 2)-GSN-treated cell and in the not silenced neighbour cell. Images correspond to the results presented in merged images in
panel B, analysed along the horizontal lines drawn in panel D. Scale bar =5 μm. Histograms show the quantification of fluorescence intensity
profiles of cortical F-actin in a series of cells (12 cells per series of siRNA(1 + 2)-GSN- and scrambled-treated cells) analysed by line scanning
confocal microscopy (8 cortical points analyzed per cell). (E) Flow cytometry analysis of F-actin in scrambled- (control, taken as 100% F-actin
expression) or siRNA(1 + 2)-GSN-treated cells. In B and E, data are mean ± s.e.m of three independent experiments carried out in triplicate.
**p < 0.01, *p < 0.05, Student’s t-test.
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Figure 7 Gelsolin knockdown restricts HIV-1 Env-mediated membrane fusion and infection in permissive cells, regardless viral tropism.
(A) Luciferase-based assay of viral entry and infection by non-replicative X4- and R5-tropic HIV-1 viral strains in siRNA1-GSN- or siRNA2-GSN
-silenced permissive lymphocytes (viral entry and infection was considered 100% in cells transfected with scrambled siRNA, i.e., controls). All the
data were corrected using the values of non-productive infection (baseline) obtained in the presence of a neutralizing anti-CD4 mAb (5 μg/mL)
under the same experimental conditions. A luciferase-based assay with equal inputs of pseudotyped VSV-G virions was performed to control the
specificity of gelsolin knockdown-mediated effects on HIV-1 viral entry and infection, and by using specific siRNA1-GSN or siRNA2-GSN oligos.
These data were corrected with non-productive baseline values obtained using non-infective virus-like particles lacking VSV-G Env under the
same experimental conditions. Data are mean ± s.e.m. of three independent experiments carried out in triplicate. Bottom, Western blot of
endogenous gelsolin knockdown prior to infection (top, infection histograms), showing representative data for each experimental condition. Cell-
surface expression of viral receptors was analyzed under each experimental condition as shown in Figure 6B. (B) Effect of specific gelsolin
silencing (siRNA(1 + 2)-GSN) in HeLa P5 cells on HIV-1 Env-mediated membrane fusion measured by β-Galactosidase production, and referred to
the scrambled control condition (100% of membrane fusion). Treated HeLa P5 cells were fused with HeLa cells expressing X4-tropic (243) or R5-
tropic (ADA) Env, in the presence or absence of an anti-CD4 mAb. Western blot of endogenous gelsolin knockdown prior to cell-to-cell fusion,
showing representative data for each experimental condition. Cell-surface expression of viral receptors was analyzed under each experimental
condition. Data are mean ± s.e.m. of four independent experiments carried out in triplicate * p < 0.05, ** p < 0.01, *** p < 0.001, Student’s t-test.
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(Figure 8A, panel a4, 27% of cells). No F-actin was
detected in the inner part of these aberrant pseudopo-
dia, although F-actin did form a basal belt (Figure 8A,
panel a4). Aberrant pseudopodia were not formed in cells
transfected with scrambled oligos, which exhibited normal
pseudopodium formation with an F-actin capping region
(Figure 8A, panel a3, 25% of cells).
These results indicate that the actin-severing activity
of endogenous gelsolin is required by HIV-1 to ensure
normal actin dynamics and the appropriate amount of
cortical actin accumulates at viral entry regions, where
pseudopodia are subsequently formed. Accordingly, cells
in which endogenous gelsolin is absent or reduced arerefractory to HIV-1 entry and infection, due to alter-
ations in these F-actin-dependent events. We and other
groups demonstrated the importance of HIV-1-mediated
cortical actin dynamics to promote the redistribution
and clustering of CD4-CXCR4 and -CCR5 to one pole of
the cell, events that enhance the initial cooperative
virus-cell contacts, subsequent fusion pore formation,
viral entry and infection [6-8]. Thus, we analyzed the
effect of endogenous gelsolin knockdown on HIV-1 Env-
gp120-induced-viral receptor redistribution and aggrega-
tion in permissive lymphocytes by confocal microscopy
(Figure 9). The homogeneous distribution of CD4 and
CXCR4 or CCR5 receptors on the plasma membrane of
CEM.NKR-CCR5 permissive cells (Figure 9A and C,
Figure 8 Gelsolin controls HIV-1 Env-gp120-induced cortical actin reorganization and capping, and the changes in pseudopodia
morphology. (A) HIV-1 Env-gp120-induced cortical F-actin redistribution and cell morphologies of siRNA(1 + 2)-GSN-silenced lymphocytes,
illustrated in the cartoons shown on the left (from a1 to a4). a1, a series of confocal images showing the distribution of endogenous gelsolin and
F-actin in the absence of any Env-gp120 stimulus (control, no capping) and in endogenous gelsolin-silenced cells suppressed using a
combination of fluorescent siRNA(1 + 2)-GSN oligos. Scrambled fluorescent oligos were used to control for RNA interference. Cells lacking gelsolin
accumulated more cortical actin than control cells. a2, a series of confocal images shows HIV-1 Env-gp120-induced distribution of endogenous
gelsolin and F-actin in control cells. An F-actin capping region was observed in 11% of the 200 cells counted, with a pseudopodium evident in
some cases. a3, a series of confocal images shows HIV-1 Env-gp120-induced formation of a pseudopodium containing the F-actin capping
region, associated with gelsolin, in cells transfected with fluorescent scrambled siRNA. An F-actin capping region is visible within the prominent
pseudopodium (25% of the 200 cells counted). a4, a series of confocal images shows aberrant HIV-1 Env-gp120-induced pseudopodium
formation and the absence of an F-actin capping region in siRNA(1 + 2)-GSN-silenced lymphocytes. An F-actin belt (asterisk) is visible at the base
of the aberrant large pseudopodium, which contains no F-actin in its inner region (27% of the 200 siRNA(1 + 2)-GSN-silenced cells counted,
where endogenous gelsolin levels were reduced together with an increase of cortical F-actin levels). This profile was not observed in control cells
transfected with scrambled siRNA in any experimental condition. In all panels, scale bar = 5 μm and one representative experiment of three with
merged images are shown. Scale bar = 5 μm.
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Figure 9 Gelsolin knockdown inhibits the redistribution and clustering of CD4-CXCR4 and CD4-CCR5 induced by HIV-1 Env-gp120.
Confocal microscopy analysis of CD4 and CXCR4 (A) or CCR5 (C) distribution in control CEM.NKR-CCR5 cells transfected with fluorescent
scrambled siRNA or siRNA(1 + 2)-GSN. Merged images show the co-localization of CD4-CXCR4 (A) or -CCR5 (C) at the plasma membrane. In
(B) and (D), a series of xy midsections shows the HIV-1 Env-gp120-induced redistribution of CD4-CXCR4 and -CCR5, respectively, to one pole of
the cell in CEM.NKR-CCR5 cells expressing scrambled Alexa 546 oligos 1 hour after exposure to rs-gp120IIIB (5 μg/mL) at 37°C (capping, series of
images). Merged images show cell surface CD4-CXCR4 (B) or -CCR5 (D) co-localization. In contrast, HIV-1 Env-gp120-induced CD4-CXCR4 and -
CCR5 redistribution was not observed in cells transfected with siRNA(1 + 2)-GSN oligos (74% and 54% of cells showing no capping, respective
series of images in (B) and (D)). These cells exhibited no CD4-CXCR4 or –CCR5 capping, although aberrant CD4 and CXCR4 or CCR5 redistribution
and aberrant pseudopodium formation was evident (see white arrows in (B) or (D), respectively). The CD4-CXCR4 and -CCR5 clustering (35% and
45% of capping, respectively), the no capping and aberrant CD4-CXCR4 and -CCR5 distribution (26% and 46%, respectively) are reflected as a
percentage of the 200 cells counted for each experimental condition, the data representing the results of three independent experiments. Scale
bar = 5 μm. One representative experiment of three is shown per each experimental condition.
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cells treated with the rs-gp120IIIB viral protein (Figure 9B
and D, scrambled (rs-gp120), respectively). Thus, the
CD4 and CXCR4 or CCR5 receptors redistributed to
one pole of the activated cells, where they formed a large
cluster or capping region (Figure 9B, 35% of cells; and
9D, 45% of cells). However, no receptor clustering was
observed at the pole of cells transfected with gelsolin
siRNA (Figure 9B and 9D, siRNA(1 + 2)-GSN (rs-gp120)),
in which CD4 and CXCR4 or CCR5 were abnormally
redistributed along aberrant pseudopodia (Figure 9B,
26% of cells, and 9D, 46% of cells, respectively) consist-
ent with the F-actin labelling in similar experimental
conditions (see aberrant pseudopodium in Figure 8A,
panel a4). This aberrant distribution of the cell-surface
receptors required for HIV-1 infection, together with the
impaired HIV-1 Env-gp120-mediated cortical actin
reorganization and aberrant pseudopodium formation,
might be responsible for the refractory behaviour of per-
missive lymphocytes lacking endogenous gelsolin.
Taken together, our data suggest that the actin-
severing activity of gelsolin is fundamental for HIV-1 to
influence cortical actin dynamics, and to appropriately
adjust the amounts of actin available for reorganization
during viral fusion, entry and infection. Moreover, we
demonstrate that the influence of gelsolin on cortical
actin affects HIV-1 Env-gp120 triggered CD4-CXCR4 or
CD4-CCR5 clustering and HIV-1 Env-mediated cell-to
-cell fusion, regardless viral Env tropism. Efficient HIV-1
fusion, entry and infection is therefore sensitive to the
expression of gelsolin and its actin-severing activity.
Hence, endogenous gelsolin can act as a limiting factor
for early HIV-1 infection at a pre-fusion step.
Discussion
In the present work, we analyzed the functional effect of
cortical actin filament severing on early HIV-1 infection
in permissive lymphocytes, and investigated whether
gelsolin can compromise the viral-induced F-actin
reorganization and viral receptor capping events re-
quired for HIV-1 fusion and infection. Specific binding
of the HIV-1 Env-gp120 protein to CD4 initiates signal-
ling via moesin [6] and filamin-A [7], resulting in actin-
dependent receptor clustering (reviewed in [1-3]). The
recruitment of sufficient receptor/co-receptor complexes
via actin polymerization is required to initiate efficient viral
fusion and entry. However, the highly dynamic network of
cortical actin may form a barrier to fusion pore enlarge-
ment and the passage of the capsid into the cytoplasm
[8,11,26]. Activation of cofilin, an actin depolymerization
factor, is required to overcome the barrier generated by
cortical actin in resting T cells, in a virus/cell post-fusion
step [8]. Based on the promotion and impairment HIV-1
fusion and entry by moesin and cofilin or syntenin-1,respectively, cortical actin has been proposed to be dynam-
ically and temporally remodelled by the virus itself during
early HIV-1 infection [6,8,10]. Interference with this
process inhibits HIV-1 viral fusion and infection,
suggesting that dynamic intact actin is required for efficient
viral fusion and infection (reviewed in [1,3]). Moreover, it
is plausible that the action of other actin cytoskeleton-
associated cellular components may be crucial for early
HIV-1 entry and infection, as proposed here for gelsolin.
Our results indicate that overexpressed gelsolin co-
localizes with cortical F-actin in the cytoplasm of per-
missive T lymphocytes. Gelsolin binds to actin filaments
with high affinity (Kd of 50 nM) and it is thought to
sever actin filaments (reviewed in [14]). After severing,
gelsolin remains attached to the barbed ends of the
filaments as a cap, thereby preventing the reannealing
of actin fragments, and it constitutively co-localizes
with the modified actin-filaments [21]. We found that
overexpression of functional gelsolin diminished the
amount of F-actin in permissive lymphocytes, which
had a thinner F-actin cortex than the corresponding
controls. In the cell cortex, gelsolin co-localized with
F-actin without affecting the cell-surface expression of
CD4, CXCR4 and CCR5 co-receptors, which appeared
to be functional in our experimental conditions as they
underwent normal ligand-stimulated internalization. By
contrast, specific silencing of endogenous gelsolin expres-
sion increased the amount of cortical F-actin in the cell.
Taken together, these results suggest that intracellular
gelsolin severs or trims actin filaments in permissive
T cells.
The studies of early HIV-1 infection by single-cycle vi-
ruses indicate that HIV-1 entry and infection is restricted
when gelsolin is overexpressed. While HIV-1 Env-gp120
triggers cortical F-actin reorganization and polar cluster-
ing in permissive lymphocytes under control conditions,
as described previously [6], the F-actin reorganization and
localization at one pole of the cell induced by HIV-1 Env-
gp120 was impaired in cells overexpressing functional
gelsolin. Moreover, this effect was directly correlated with
the inhibition of early HIV-1 infection in these cells, and
with the inhibition of HIV-1 Env-mediated cell-to-cell
fusion in HeLa permissive cells overexpressing gelsolin.
Hence, our data indicate that cortical actin reorganization
is fundamental for efficient viral fusion, entry and infec-
tion. The amount of actin available and its arrangement in
the cortex appears to be controlled by the activity of the
gelsolin expressed by the cell, suggesting that gelsolin can
restrict early HIV-1 infection.
It is conceivable that the expression of gelsolin may
increase in permissive cells in response to specific signals,
resulting in altered actin-cytoskeleton dynamics due to
the severing of cortical actin filaments (i.e., bypassing the
signals mediating by early HIV-1 infection). This activated
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fractory to HIV-1 infection in vivo. Indeed, gelsolin
overexpression also inhibits HIV-1 Vpr-induced T-cell
apoptosis by blocking the interaction between Vpr and
the voltage-dependent anion channel (VDAC) [27],
suggesting that gelsolin acts as a protective factor against
Vpr-induced T-cell apoptosis. Activation of gelsolin’s basal
actin-severing activity may also be important to facilitate
the establishment of HIV-1 latency in infected cells, as
suggested by the chemokine-induced, cofilin-dependent
changes observed in the actin cytoskeleton of infected
resting CD4+ T cells [28]. Further studies will be necessary
to explore this hypothesis, and to elucidate the role of
gelsolin in conditions of cell activation and infection.
The functional role of gelsolin-mediated actin severing
during HIV-1 fusion and infection was further demon-
strated in HIV-1 Env-mediated membrane fusion models
and in infected permissive lymphocytes in which
endogenous gelsolin expression had been silenced by
specific RNA interference. The degree of gelsolin silen-
cing is correlated with the extent to which HIV-1 entry
and infection, and HIV-1 Env-induced cell-to-cell fusion
were blocked in these cells. Specific gelsolin knockdown
had no effect on CD4, CXCR4 and CCR5 cell surface
expression and distribution in cells not stimulated with
HIV-1 Env-gp120. Moreover, the inhibition of HIV-1
Env-mediated membrane fusion, viral entry and infec-
tion were independent of viral tropism. These findings
were somewhat expected, as HIV-1 Env-mediated pore
fusion formation and early viral infection are directly
dependent on correct cortical actin dynamics and actin
reorganization, events known to be crucial for successful
infection with both tropic viruses [6-9].
Permissive lymphocytes transfected with gelsolin
siRNA accumulated more cortical F-actin than control
cells. Incubation with the HIV-1 Env-gp120 viral protein
provokes a redistribution of cortical actin to one pole of
control permissive cells, where it forms a discrete F-
actin capping region within small or large pseudopodia.
These changes in cell morphology and actin dynamics
are indicative of efficient cellular activation by the viral
Env-gp120 protein [6,10]. In such cases, a proportion of
the endogenous gelsolin was distributed within the F-
actin capping region, but without displaying a clear-cut
capping pattern. By contrast, no redistribution of F-actin
nor capping was mediated by the viral protein in cells
transfected with gelsolin siRNA, which also exhibited
aberrant pseudopodia formation. Aberrant pseudopodia
were characterized by the absence of detectable F-actin
in their interior and the presence of an F-actin belt at
the base of the pseudopodium. Significantly, alterations
in the morphology and retractile properties of actin-
dependent filopodia have been described in cells from
gelsolin null mice [17].Taken together, these data indicate that the actin-
severing activity of endogenous gelsolin is required by
HIV-1 to ensure that Env-gp120 induces a redistribution
of cortical actin, appropriate actin dynamics and the accu-
mulation of the necessary amount of cortical actin at the
viral-cell contact and entry regions, where pseudopodia
subsequently form. Accordingly, cells in which endogen-
ous gelsolin expression is reduced or absent are refrac-
tory to HIV-1 Env-mediated membrane fusion, viral
entry and infection due to impairment of these multiple
F-actin-driven events.
Gelsolin-mediated F-actin-severing occurs in the pres-
ence of full-length intracellular or recombinant gelsolin
[14] and the severing of F-actin occurs only when a suffi-
cient number of actin-actin bonds are broken [29]. Spe-
cific cell signalling events can lead to the formation of
plasma membrane-associated structures (e.g., lamellipodia,
pseudopodia and filopodia), a process that is regulated by
gelsolin and other related tropomyosins through the
rearrangement of actin filaments [17,18,30-34]. The actin-
severing activity of gelsolin can rapidly restructure the
cytoskeleton. In addition, differences in cortical actin con-
tent between resting memory and naive T cells are likely
to contribute to their differential susceptibility to HIV-1,
which is enhanced in resting T cells [35]. Taken together
with the present findings, these observations suggest that
HIV-1 requires a minimum level of gelsolin to drive the
restructuring of the cortical actin cytoskeleton in the areas
of viral-cell contact and viral entry, thereby ensuring effi-
cient HIV-1 Env-induced pore fusion formation and sub-
sequent viral entry and infection.
Our results also suggest that gelsolin mediates virus-
triggered receptor clustering by modulating HIV-1 Env-
gp120-mediated cortical actin dynamics. The viral pro-
tein induces a redistribution of cell-surface CD4 and
CXCR4 or CCR5 receptors to one pole of activated
control cells, an effect that is abrogated by gelsolin
overexpression or knockdown. Indeed, cells in which
gelsolin expression was silenced exhibited alterations in
the redistribution of CD4 and CXCR4 or CCR5 in aber-
rant pseudopodia, similar to the redistribution of F-actin
in equivalent circumstances. This inhibition of virus-
induced receptor clustering [6,7] may account for the
observed inhibition of HIV-1 Env-mediated membrane
fusion and early viral infection following the silencing of
gelsolin expression.
The aforementioned observations suggest that gelsolin
severs the cortical actin cytoskeleton to maintain its
proper architecture with the appropriate amount of
F-actin, ensuring its dynamic reorganization during early
HIV-1 entry and infection. As a consequence of this
dynamic reorganization of F-actin, receptors mediating
viral infection are driven to one pole of the cell where
they co-localize. Perturbing these actin- and gelsolin-
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and early HIV-1 infection, which are therefore sensitive to
the actin-severing activity of gelsolin at the plasma mem-
brane, and hence, to gelsolin expression. Accordingly, en-
dogenous gelsolin may act as a limiting factor for early
HIV-1 entry and infection. This hypothesis was validated
by analyzing the effects of gelsolin overexpression or spe-
cific knockdown on early infection with endocytotic VSV-G
pseudotyped viral particles. The impaired infectivity of
HIV-1 in gelsolin overexpressing lymphocytes, or in
gelsolin-silenced cells were complemented with VSV-G
pseudotyped virions, which fuse in low-pH endocytotic
vesicles. This is consistent with the fact that HIV-1 mainly
fuses and infects T lymphocytes by exploiting both actin-
dependent and Arf6 GTPase-regulated, clathrin-independent
, plasma membrane dynamic pathways [6-9,24,36]. However,
we cannot rule out the involvement of gelsolin in the
clathrin-endocytic VSV-G-driven viral entry route after acti-
vation of specific cellular or signalling processes.
In fact, considering all the above data and discussion,
we suggest that efficient early HIV-1 infection requires the
appropriate amount of cortical actin to be reorganized in
a specific manner during the initial virus-cell contacts.
Both these processes appear to be influenced by actin-
severing gelsolin, suggesting that alteration of gelsolin
activity or expression can restrict HIV-1 entry and infec-
tion. Therefore, both overexpression of functional gelsolin
or specific knockdown of endogenous gelsolin negatively
affects HIV-1 Env-mediated actin dynamics, entry and
infection at a pre-fusion step. Cofilin regulates early HIV-1
infection depolymerising cortical F-actin at a post-fusion
step [8], a process that may be influenced by cortical
F-actin levels, in cells where endogenous gelsolin was
silenced. It is plausible that cofilin found difficulties to
inhibit HIV-1 infection in cells presenting higher amounts
of cortical F-actin, after knockdown of endogenous gelsolin.
Moreover, gelsolin silencing impairs early HIV-1 infection
acting in a pre-fusion step, thereby preceding, and maybe
abrogating cofilin-mediated post-fusion effects on HIV-1
infection. The fact that silencing of gelsolin expression does
not completely inhibit HIV infection could be due to the
existence of cells where siRNA-GSN oligos did not cor-
rectly silenced endogenous gelsolin, as observed in cells
from new Figure 6C or D, or to the presence of other actin-
associated proteins or adaptors, such as moesin and
filamin-A [6,7], which could compensate the negative effect
of gelsolin knockdown.
These findings provide important insights into the
complex molecular and actin-associated dynamics events
that underlie early viral infection. Thus, we propose that
gelsolin is a new factor that can limit HIV-1 infection
acting at a pre-fusion step. Accordingly, cell-signals that
regulate gelsolin expression and/or its actin-severing
activity may be crucial to combat HIV-1 infection.In this matter, cell signals that upregulate or
downregulate the expression of functional gelsolin, or
that alter its cortical localization, may render putative
target cells refractory to HIV-1 infection in vivo. Virus-
mediated cell signalling may represent a potential thera-
peutic target to treat early HIV-1 infection (reviewed in
[37]) and in fact, HIV-1 Env-fusogenic activity appears
to be both Ca2+ [38] and phosphatidylinositol (4,5)-
bisphosphate (PIP2) dependent [10,22,24,36]. By activat-
ing type Iα phosphatidylinositol-4-phosphate 5-kinase
(PI4P5-K Iα) at virus-cell contact regions, HIV-1 is
known to trigger the production of this PIP2-fusogenic
lipid to promote fusion pore formation and viral infec-
tion [22], and the depletion of syntenin-1 allows a higher
pool of free PIP2 to accumulate at the plasma membrane
after HIV-1 attachment [10]. Furthermore, PIP2-associated
plasma membrane changes driven by Arf6 are crucial for
early HIV-1 infection, ensuring cell surface regeneration
when the virus fuses with and enters permissive cells
[24,36,39]. It should be noted that gelsolin is regulated by
both PIP2 and intracellular Ca
2+, which may represent
additional control points for actin dynamics in the plasma
membrane [20,32,40-43]. Gelsolin-mediated F-actin
reorganization may also drive the final stages of virus-cell
lipid mixing, favouring viral fusion at the molecular level
[44]. Given the proposed interplay between gelsolin, Ca2+
and PIP2, and the effect of gelsolin on early HIV-1 infec-
tion described here, better understanding the regulation
of intracellular gelsolin localization and activation will
be important to develop strategies to control HIV-1
infection of T lymphocytes.
Conclusions
Our findings suggest that by severing cortical F-actin,
gelsolin regulates actin dynamics, the amount of F-actin
available for reorganization, lymphocyte plasma mem-
brane morphology, and viral receptor capping during
HIV-1 viral entry and infection. The fine-tuning of
gelsolin activity is necessary to ensure the virus-driven
regulation of cell-surface receptors and of cortical actin
dynamics, events that are crucial for efficient pore fusion
formation and therefore early HIV-1 infection in T lym-
phocytes. Thus, it appears that endogenous gelsolin
maintains cortical actin dynamic during early viral infec-
tion, acting in a pre-fusion step. Hence, alteration of
gelsolin expression or activity accounts for an abnormal
HIV-1 Env-mediated cortical actin reorganization that
negatively affects early viral infection. These data
enhance our understanding of the complex molecular
events that underlie early viral infection, and highlight
the possibility of modifying gelsolin-mediated actin-
severing to present a barrier to HIV-1 infection, regard-
less of viral tropism, during the first virus-cell contacts and
membrane fusion events. Further studies will be necessary
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cellular gelsolin expression, or that modulate its actin-
severing activity, thereby altering F-actin remodelling.
Identifying such signals will also help further characterize
the role of gelsolin in HIV-1 fusion, entry and infection of
CD4+ T lymphocytes in vivo.
However, based on our results we propose that the
actin-severing gelsolin protein is a novel limiting factor
that controls early HIV-1 infection in permissive lympho-
cytes acting at a pre-fusion step.
Methods
Antibodies and reagents
The commercial mouse anti-gelsolin monoclonal anti-
body (mAb, clone GS-2C4; Sigma, St. Louis, MO) was
used here. The neutralizing mAb RPA-T4 (eBioscience,
San Diego, CA) directed against CD4 was either phyco-
erythrin (PE)-labelled (flow cytometry; confocal analysis)
or left unconjugated (inhibition of HIV-1 entry and
infection for confocal analysis). PE conjugates of the
CD184 (clone 12G5) and CD195 (clone 2D7/CCR5) (BD
Bioscience/BD PharMingen, San Jose, CA) are directed
against the second extracellular loop of CXCR4 and
CCR5, respectively. Biotinylated mouse anti-human
CXCR4 and CCR5 mAbs were purchased from BD
PharMingen. The rabbit anti-EGFP polyclonal antiserum
(pAb) was obtained from Santa Cruz Biotechnology
(Santa Cruz, CA), and the monoclonal anti-α-tubulin
from Sigma-Aldrich (Sigma-Aldrich, St. Louis, USA).
Secondary horseradish peroxidase (HRP)-conjugated
antibodies were purchased from Dako (Glostrup,
Denmark), while Alexa Fluor 568-phalloidin (to label
F-actin), Alexa Fluor 488-goat anti-mouse, Alexa Fluor
633-goat anti-mouse and NeutrAvidin Texas Red conju-
gate were purchased from Molecular Probes (Eugene,
OR). Endotoxin-free, recombinant soluble (rs) X4-tropic
HIV-1 Env-gp120-IIIB protein (rs-gp120IIIB) was pro-
duced in Escherichia coli by Innogenetics (Ghent,
Belgium), and used as described previously [6,22]. Stro-
mal cell-derived factor (SDF)-1α (CXCL12) was kindly
synthesized and provided by Francoise Baleux (Institut
Pasteur, Paris, France) [24,45,46].
Cells
The human CEM.NKR-CCR5 permissive cell line (cata-
log number 4376, NIH AIDS Research and Reference
Reagent Program) was grown at 37°C in a humidified
atmosphere with 5% CO2 in RPMI 1640 medium (Lonza,
Verviers, Belgium) supplemented with 10% foetal calf serum
(Lonza), 1% L-glutamine, and 1% penicillin-streptomycin.
Cells were passaged every 3 days. The HeLa-P5 cells,
constitutively expressing CXCR4 and stably transfected
with human CD4 and CCR5 cDNAs and with an HIV-
long terminal repeat-driven-β-galactosidase reportergene [23,45,47], as well as, HeLa-243 and HeLa-ADA cells,
co-expressing the Tat and X4- and R5-tropic HIV- 1-Env
proteins, respectively, were provided by Dr. M. Alizon
(Hôpital Cochin, Paris, France) and cultured as previously
described [23,45,47]. The 293T cell line was similarly cul-
tured in supplemented DMEM (Lonza). Cells were
harvested and cultured to 50-70% confluence in fresh
supplemented DMEM 24 hours before cell transfection
with viral or human DNA constructs.
Western blotting
Protein expression was determined in Western blots of
cell lysates. Briefly, 24 h after nucleofection of cells with
different cDNA constructs (pEGFP-N1, gelsolin-EGFP,
EGFP-pSUPER or EGFP-pSUPER-gelsolin) or short inter-
ference oligonucleotides (oligos) using specific Amaxa kits
(Amaxa, Köln, Germany), cells were lysed at 4°C in 1%
Triton-X100 sample buffer supplemented with a protease
inhibitor cocktail (Roche Diagnostics GmbH, Mannheim,
Germany). Equivalent amounts of protein, as determined
using the bicinchoninic acid method, were separated by
SDS-PAGE on 10% gradient gels and electroblotted
onto 0.45 μm polyvinylidene difluoride membranes
(PVDF; Millipore Corporation, Billerica, MA) using
Trans-blot Turbo (Bio-Rad, Hercules, CA). Membranes
were then probed with specific antibodies and the pro-
teins recognised were detected by luminescence using
the ECL System (Pierce), and analyzed using a
ChemiDoc MP device and Image LabTM Software,
Version 4.0.1 (Bio-Rad).
Messenger RNA silencing
We designed the following short interference oligos
specifically directed against the indicated mRNA se-
quences of gelsolin (GSN): siRNA1-GSN (position 611–
629; sense: 50-acagcaaucgguaugaaag-30-dTdT; antisense:
50-cuuucauaccgauugcugu-30-dTdT) and siRNA2-GSN
(position 1692–1710; sense: 50-cgaugccuuuguucugaaa
-30-dTdT; antisense: 50-uuucagaacaaaggcaucg-30-dTdT).
Alexa 546-conjugated or non-fluorescent siRNA oligos,
and scrambled control siRNA oligos (Alexa 546-
conjugated or not), were obtained from Sigma-Aldrich.
For confocal microscopy experiments, we used a
mixture of both Alexa 546-conjugated siRNA-GSN
oligos (siRNA(1 + 2)-GSN) to induce specific siRNA-
mediated silencing of endogenous gelsolin expression.
Permissive CEM.NKR-CCR5 cells were nucleofected
with 1 μM siRNA-GSN or a commercial scrambled
control siRNA using specific Amaxa kits (Amaxa), and
the cells were assayed 24 h later, as described previ-
ously [6,22,24,48]. The siRNA for gelsolin induced spe-
cific interference of protein expression for at least 72 h,
as witnessed in Western blots (data not shown). Cells
nucleofected with scrambled or specific siRNA oligos
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antibodies in Western blots to determine the endogen-
ous gelsolin silencing.
Viral DNA constructs and plasmids
The pNL4-3.Luc.R-E- provirus (catalog number 6070013),
the X4-tropic HXB2-envelope (env, catalogue number
5040154) and R5-tropic pCAGGS-SF162-gp160-env (cata-
logue number 3041817) glycoprotein vectors, and the
pHEF-VSV-G vector (catalogue number 4693) encoding
the vesicular stomatitis virus G (VSV-G) protein, were
obtained via the NIH AIDS Research and Reference
Reagent Programme. For gelsolin-EGFP expression, total
RNA from CEM.NKR-CCR5 T-cells was extracted, tran-
scribed to cDNA, and a gelsolin construct lacking the stop
codon was generated by Expand High Fidelity PCR using
cDNA as a template and 50-GGAATTCGCCACCATGGT
GGTGGAACACCCCGAGTTCC-30 (sense) and 50-CGG
GATCCCTGGCAGCCAGCTCAGCCATGGCCC-30 (anti-
sense) primers. The amplified gelsolin product was cloned
into pEGFP-N1 (Clontech, Palo Alto, CA) between the
EcoRI and BamHI restriction sites (Takara Bio Inc., Japan).
Control pEGFP-N1 (Clontech) was used to express free
EGFP in permissive lymphocytes.
To create a system which allowed us to express both
free EGFP and gelsolin proteins, we cloned the human
gelsolin coding sequence into pSUPER.retro.neo + GFP
(Oligoengine, WA). This plasmid was digested with
HindIII and BglII restriction enzymes (New England
Biolabs, MA) and gelsolin was amplified from the GSN.
EGFP construct used in this work and by using the fol-




Polymerase Chain Reaction (PCR) was performed by using
Phire Hot Start II DNA Polymerase (ThermoScientific, MA)
and amplification conditions were such as 98°C/30sec; 35
cycles of 98°C/5sec, 68°C/5sec, 72°C/30sec; and 72°C/1min.
The gelsolin amplicon was also digested with both HindIII
and BglII, consecutively cloned into the HindIII/BglII site on
pSUPER.retro.neo +GFP (named in this work as EGFP-
pSUPER-gelsolin) and positive clones were selected through
Ampicilin resistance. Control pSUPER.retro.neo +GFP plas-
mid is used as a control for expression of free EGFP (named
EGFP-pSUPER in this work).
Production of viral particles
Replication-deficient luciferase-HIV-1 or -pseudotyped
VSV-G viral particles were obtained as described previ-
ously [6,22-24]. Briefly, replication-deficient viral parti-
cles were derived from the luciferase-expressing reporter
virus HIV/Δnef/Δenv/luc + (in which the luciferase gene
is inserted into the nef ORF and does not express theenvelope glycoprotein) with an X4-tropic (Lai), R5-
tropic (SF162) or VSV-G Env glycoprotein. X4- or R5-
tropic HIV-1 or pseudotyped VSV-G viral particles were
produced in 12-wells plates by co-transfecting 293T cells
(70% confluence) with pNL4-3.Luc.R-E- (10 μg) and X4-
tropic (HXB2-env) or R5-tropic (pCAGGS SF162 gp160)
or VSV-G (pHEF-VSV-G) Env glycoprotein vector (10
μg). Viral plasmids were transduced in 293T cells using
X-tremeGENE HP DNA transfection reagent (Roche
Diagnostics). After the addition of X-tremeGENE HP to
the viral plasmids (at a plasmid:X-tremeGENE HP ratio of
1:3 [wt/v], for pNL4-3/R5, pNL4-3/X4 and pNL4-3/VSV-
G viral vector combinations), the solution was mixed in
100 μL of DMEM medium (without serum or antibiotics)
and incubated for 15 min at room temperature prior to
adding it to 293T cells. The cells were cultured for 48 h to
allow viral production. The viruses were harvested and
the supernatant was clarified by centrifugation at 3000 x g
for 30 min, filtered (0.45 μm pore size) and concen-
trated using Amicon Ultra-4 Centrifugal filter devices
(Millipore). Virions were then stored at −80°C. Viral stocks
were normalized by p24-Gag content, determined using an
enzyme-linked immunosorbent assay (GenscreenTM HIV-
1 Ag Assay; Bio-Rad, Marnes-la-Coquette, France).
Luciferase viral entry and infection assay
Untreated or nucleofected CEM.NKR-CCR5 cells (9 × 105
cells in 24-well plates with 20 μg/mL of polybrene) were
infected for 2 h with a synchronous dose of luciferase-
based X4- or R5-tropic HIV-1 or pseudotyped VSV-G
viral inputs (500 ng of p24), in a total volume of 1 mL
RPMI 1640 (by centrifugation at 1,200 g at 25°C), and
again for 4 h at 37°C, as described previously [6,22-24].
Unbound virus was then removed by washing the infected
cells and 48 h after infection, luciferase activity was mea-
sured using a luciferase assay kit (Biotium, Hayward,
CA) and a microplate reader (VictorTM X5, PerkinElmer,
Waltham, MA). Where indicated, permissive cells were
pretreated with an anti-CD4 neutralizing mAb (5 μg/mL).
The data were analyzed using GraphPad Prism 5.0 soft-
ware (GraphPad Software, San Diego, CA) and the protein
content was measured using the bicinchoninic acid
method.
HIV-1-Env-mediated cell-to-cell fusion assay
A β-Galactosidase cell fusion assay was performed as
previously described [23,45,47]. Briefly, HeLa-243 or
HeLa ADA cells were mixed with previously treated
HeLa-P5 cells (overexpressing free EGFP, gelsolin-EGFP,
free gelsolin, scrambled or siRNA(1 + 2)-GSN oligos), in
96-well plates, in a 1:1 ratio (20,000 total cells), under
each experimental condition. These co-cultures were
kept at fusion for 16 h at 37°C. The fused cells were
washed with Hanks’ balanced salt solution, lysed, and
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cence (β-Galactosidase reporter gene assay; Roche Diag-
nostics, Germany). Anti-CD4 neutralizing mAb (5 μg/ml
was preincubated in HeLa-P5 cells for 30 min at 37°C be-
fore co-culture with Env +HeLa cells (243 or ADA) was
used as a control for the blockage of cell fusion.
Immunofluorescence
Transfected immunofluorescent CEM.NKR-CCR5 (1 ×
106 cell/point) cells were washed three times with PBS
and fixed for 5 min in 3% paraformaldehyde in PBS. The
cells were again washed three times with PBS and where
indicated, permeabilized with 0.1% Triton X-100 in PBS.
After washing with PBS, the cells were immunostained
for 1 h at room temperature with Alexa 568-labeled
phalloidin, Alexa 633-labeled goat anti-mouse against
CD4 (previously incubated with a specific mAb), or
NeutrAvidin Texas Red conjugate against anti-CXCR4-
or anti-CCR5-biotinylated Abs (previously incubated
with a primary specific mAb against viral co-receptors),
all diluted in PBS containing 0.1% BSA. Coverslips were
mounted in Mowiol-antifade (Dako) and imaged in xy
midsections with a FluoView FV1000 confocal micro-
scope using a 1.35 NA objective (60x; Olympus, Center
Valley, PA) for high-resolution imaging of fixed cells.
The final images were analyzed and quantified with
MetaMorph software (Universal Imaging, Downington,
PA). Line scan analysis of the expression and distribu-
tion of cortical F-actin in gelsolin-EGFP, free gelsolin
(co-expressed with free EGFP using a pSUPER plasmid)
and free EGFP overexpressing cells was quantified using
MetaMorph software, as described previously [48].
CD4-CXCR4 and CD4-CCR5 clustering assay
Viral receptor capping assays were performed as described
previously [6,49]. Briefly, CEM.NKR-CCR5 permissive
cells expressing CD4, CXCR4 and CCR5 were co-cultured
with the HIV-1 Env-gp120 protein rs-gp120IIIB (5 μg/ml)
for 1 hour at 37°C. The viral Env-gp120 protein was then
washed out and the cells were fixed with 3% parafor-
maldehyde. The distribution of CD4 and CXCR4 or CD4
and CCR5 at the cell-surface of gelsolin-EGFP or siRNA
(1 + 2)-GSN Alexa 546 expressing cells (and their corre-
sponding controls) was determined by immunofluores-
cence and analyzed by confocal microscopy, as described
above. The final images were analyzed and quantified with
MetaMorph software.
F-actin capping assay
Confocal analysis of HIV-1 Env-gp120-induced F-actin re-
distribution was performed in permissive lymphocytes as
described previously [6]. Cells in which endogenous
gelsolin was previously knocked-down by transfection
with fluorescent siRNA(1 + 2)-GSN Alexa 546 (scrambledAlexa 546 oligos were used as a control), or those in which
gelsolin-EGFP or free gelsolin (co-expressed with free
EGFP using a pSUPER plasmid) was overexpressed
(overexpression of free EGFP was used as a control, in
both experimental conditions) were co-cultured with the
HIV-1 Env-gp120 protein rs-gp120IIIB (5 μg/ml) for 1 hour
at 37°C. The viral Env-gp120 protein was then washed
out and the cells were fixed with 3% paraformaldehyde.
The cells were washed three times with PBS after fix-
ation and then permeabilized with 0.1% Triton X-100
in PBS. The cells were subsequently washed with PBS
after permeabilization and immunostained for 1 h at
room temperature with Alexa 568-labeled phalloidin.
The siRNA(1 + 2)-GSN Alexa 546-treated cells were
also immunostained with an Alexa 488-conjugated goat
anti-mouse antibody against endogenous gelsolin or
Alexa 633-conjugated anti-gelsolin Ab in the case of
cells expressing free EGFP. Cells were analyzed by con-
focal microscopy, as described above, to obtain high-
resolution images of the fixed, permeabilized cells. The
final images were analyzed and quantified using
MetaMorph software.
Flow cytometry analysis
For cell-surface analysis of viral receptors, CEM.NKR-
CCR5 and HeLa P5 cells (3 × 106 cell/point)
nucleofected with different DNA constructs (pEGFP-N1,
0.5 μg; gelsolin-EGFP, 3 μg; EGFP-pSUPER or EGFP-
pSUPER-gelsolin, 0.5 or 3 μg, respectively; or the RNA
interfering oligos siRNA(1 + 2)-GSN or scrambled
siRNA, 1 μM) were incubated with PE-labelled specific
antibodies against CD4, CXCR4 or CCR5 (1/20 dilution)
for 1 h at 4°C to prevent receptor internalization. Next,
the cells were washed with ice-cold PBS, fixed in PBS
containing 3% paraformaldehyde and analyzed by flow
cytometry (XL-MCL System, Beckman-Coulter Inc.). For
intracellular analysis of cortical F-actin, permissive CEM.
NKR-CCR5 cells (3 × 106 cell/point) nucleofected with
the different DNA constructs (pEGFP-N1, 0.5 μg;
gelsolin-EGFP, 3 μg; or the RNA interfering oligos
siRNA(1 + 2)-GSN or scrambled siRNA, 1 μM) were
fixed in PBS containing 3% formaldehyde and then
permeabilized in 0.1% Triton X-100 buffer. The cells
were then incubated with Alexa 568-labeled phalloidin
for 1 h at room temperature, washed with PBS, fixed in
PBS containing 3% paraformaldehyde and finally ana-
lyzed by flow cytometry (XL-MCL system, Beckman-
Coulter Inc.).
Flow cytometry analysis of cellular F-actin content
The intracellular actin content was analyzed as described
previously [6]. Briefly, 24 h after transfection with the
different DNA constructs (pEGFP-N1, 0.5 μg; gelsolin-
EGFP, 3 μg), or with scrambled or siRNA(1 + 2)-GSN
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intracellular actin dynamics with a solution containing 3%
formaldehyde in PBS, 1% Triton X-100, and 5 μg/ml Alexa
Fluor 568-phalloidin. Cells were incubated for 15 minutes
at 37°C and washed once in PBS and the levels of intracel-
lular polymerized actin (F-actin) were determined using a
FACScan flow cytometer (XL-MCL System, Beckman-
Coulter Inc.).
Ligand-induced CXCR4 endocytosis
CEM.NKR-CCR5 cells (0.5 × 106 cells/mL) were incu-
bated with either 50 or 200 nM of SDF-1α for 1 h at
37°C in serum-free RPMI 1640, as described previously
[23,24,46]. The cells were then incubated for 3 min at
4°C in an acidic buffer (50 mM glycine [pH 3.0]), to stop
receptor endocytosis and remove CXCR4-bound SDF-1α
that masks cell-surface CXCR4 receptor recognition by
specific mAbs. The cells were then washed twice with
ice-cold PBS and 0.1% BSA, incubated with specific anti-
receptor PE-conjugated mAbs (1:50) for 1 h at 4°C, and
then fixed with 3% paraformaldehyde in PBS. Samples
were analyzed on a flow cytometer (XL-MCL System) to
measure cell-surface receptor labelling in free EGFP + and
gelsolin-EGFP + cells. Basal cell fluorescence intensity for
cell-surface CXCR4 was determined by staining cells with
a PE-conjugated IgG2a isotype control.
Additional file
Additional file 1: Flow cytometry analysis of cell viability of
permissive cells, under different experimental conditions.
Description of data: (A) Flow cytometry-based analysis of propidium
iodide uptake (FL-3) in pcDNA.3-, EGFP- and gelsolin-EGFP-transfected
permissive cells (top panel, permissive lymphocyte cells; bottom panel,
permissive HeLa cells) at 24 h post-transfection. Expression of EGFP- or
gelsolin-EGFP is monitored in FL-1. Quantification of propidium iodide
uptake (FL-3) by these treated cells (FL-1) is indicated in regions R of
plots (represented as the percentage of total cells analyzed), per each
experimental condition. A representative experiment of three is shown.
(B) Flow cytometry-based analysis of propidium iodide uptake (FL-3) in
scrambled and siRNA(1 + 2)-GSN-treated permissive cells (top panel,
permissive lymphocyte cells; bottom panel, permissive HeLa cells) at 24 h
post-nucleofection. Quantification of propidium iodide uptake (FL-3) by
these treated cells (SSC, Side Scatter) is indicated in regions R of plots,
per each experimental condition. A representative experiment of three is
shown. In (A) and (B), not any significant toxicity is observed under each
experimental condition.
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